Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-048617
Filing Date
2025-05-14
Accepted
2025-05-14 17:26:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 10222
2 EXHIBIT 99.1 tm2515023d1_ex99-1.htm EX-99.1 6520
  Complete submission text file 0001104659-25-048617.txt   18252
Mailing Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217
Business Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217 210-698-5334
bioAffinity Technologies, Inc. (Subject) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94171 | Film No.: 25947242
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)

Mailing Address P.O. BOX 460633 SAN ANTONIO TX 78246-0633
Business Address
Crumly Richard K. (Filed by) CIK: 0001783794 (see all company filings)

Type: SCHEDULE 13G